Russia is increasing exports of its anti-COVID-19 vaccines this year, with the biggest markets being Argentina, Kazakhstan and India, reports The Pharma Letter’s local correspondent.
According to data of the Federal Customs Service, in the first eight months of the current year Russia exported 362.5 tons of vaccines worth $713.7 million.
It is reported that the majority of supplies were accounted for by Russia’s flagship Sputnik V vaccine, which so far has already been approved in 70 countries and fully meets the domestic demand.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze